These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 23922981)

  • 1. Overexpression of CTHRC1 in hepatocellular carcinoma promotes tumor invasion and predicts poor prognosis.
    Chen YL; Wang TH; Hsu HC; Yuan RH; Jeng YM
    PLoS One; 2013; 8(7):e70324. PubMed ID: 23922981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
    Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
    J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Collagen triple helix repeat containing-1 negatively regulated by microRNA-30c promotes cell proliferation and metastasis and indicates poor prognosis in breast cancer.
    Lai YH; Chen J; Wang XP; Wu YQ; Peng HT; Lin XH; Wang WJ
    J Exp Clin Cancer Res; 2017 Jul; 36(1):92. PubMed ID: 28697793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer.
    Guo B; Yan H; Li L; Yin K; Ji F; Zhang S
    J Ovarian Res; 2017 Oct; 10(1):69. PubMed ID: 29021002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CTHRC1 acts as a prognostic factor and promotes invasiveness of gastrointestinal stromal tumors by activating Wnt/PCP-Rho signaling.
    Ma MZ; Zhuang C; Yang XM; Zhang ZZ; Ma H; Zhang WM; You H; Qin W; Gu J; Yang S; Cao H; Zhang ZG
    Neoplasia; 2014 Mar; 16(3):265-78, 278.e1-13. PubMed ID: 24726140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide screening identified that miR-134 acts as a metastasis suppressor by targeting integrin β1 in hepatocellular carcinoma.
    Zha R; Guo W; Zhang Z; Qiu Z; Wang Q; Ding J; Huang S; Chen T; Gu J; Yao M; He X
    PLoS One; 2014; 9(2):e87665. PubMed ID: 24498348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagen triple helix repeat containing 1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation and motility.
    Tameda M; Sugimoto K; Shiraki K; Yamamoto N; Okamoto R; Usui M; Ito M; Takei Y; Nobori T; Kojima T; Suzuki H; Uchida M; Uchida K
    Int J Oncol; 2014 Aug; 45(2):541-8. PubMed ID: 24841500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-425-5p promotes invasion and metastasis of hepatocellular carcinoma cells through SCAI-mediated dysregulation of multiple signaling pathways.
    Fang F; Song T; Zhang T; Cui Y; Zhang G; Xiong Q
    Oncotarget; 2017 May; 8(19):31745-31757. PubMed ID: 28423650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of fibulin-5 on adhesion, migration and invasion of hepatocellular carcinoma cells via an integrin-dependent mechanism.
    Tang JC; Liu JH; Liu XL; Liang X; Cai XJ
    World J Gastroenterol; 2015 Oct; 21(39):11127-40. PubMed ID: 26494967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen triple helix repeat containing-1 promotes pancreatic cancer progression by regulating migration and adhesion of tumor cells.
    Park EH; Kim S; Jo JY; Kim SJ; Hwang Y; Kim JM; Song SY; Lee DK; Koh SS
    Carcinogenesis; 2013 Mar; 34(3):694-702. PubMed ID: 23222813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of p57 expression and RhoA overexpression are associated with poor survival of patients with hepatocellular carcinoma.
    Hu T; Guo H; Wang W; Yu S; Han L; Jiang L; Ma J; Yang C; Guo Q; Nan K
    Oncol Rep; 2013 Oct; 30(4):1707-14. PubMed ID: 23842948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.
    Liu T; Chen J; Xiao S; Lei X
    Tumour Biol; 2016 May; 37(5):6419-28. PubMed ID: 26631039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma.
    Wang WM; Xu Y; Wang YH; Sun HX; Sun YF; He YF; Zhu QF; Hu B; Zhang X; Xia JL; Qiu SJ; Zhou J; Yang XR; Fan J
    Oncotarget; 2017 Jul; 8(29):47121-47135. PubMed ID: 28454092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The collagen triple helix repeat containing 1 facilitates hepatitis B virus-associated hepatocellular carcinoma progression by regulating multiple cellular factors and signal cascades.
    Zhang R; Cao Y; Bai L; Zhu C; Li R; He H; Liu Y; Wu K; Liu F; Wu J
    Mol Carcinog; 2015 Dec; 54(12):1554-66. PubMed ID: 25263696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RUNX2 promotes hepatocellular carcinoma cell migration and invasion by upregulating MMP9 expression.
    Wang Q; Yu W; Huang T; Zhu Y; Huang C
    Oncol Rep; 2016 Nov; 36(5):2777-2784. PubMed ID: 27666365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TMPRSS4 facilitates epithelial-mesenchymal transition of hepatocellular carcinoma and is a predictive marker for poor prognosis of patients after curative resection.
    Wang CH; Guo ZY; Chen ZT; Zhi XT; Li DK; Dong ZR; Chen ZQ; Hu SY; Li T
    Sci Rep; 2015 Jul; 5():12366. PubMed ID: 26190376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C1GALT1 promotes invasive phenotypes of hepatocellular carcinoma cells by modulating integrin β1 glycosylation and activity.
    Liu CH; Hu RH; Huang MJ; Lai IR; Chen CH; Lai HS; Wu YM; Huang MC
    PLoS One; 2014; 9(8):e94995. PubMed ID: 25089569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ITGBL1 promotes cell migration and invasion through stimulating the TGF-β signalling pathway in hepatocellular carcinoma.
    Huang W; Yu D; Wang M; Han Y; Lin J; Wei D; Cai J; Li B; Chen P; Zhang X
    Cell Prolif; 2020 Jul; 53(7):e12836. PubMed ID: 32537856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SRPX2, an independent prognostic marker, promotes cell migration and invasion in hepatocellular carcinoma.
    Lin X; Chang W; Wang Y; Tian M; Yu Z
    Biomed Pharmacother; 2017 Sep; 93():398-405. PubMed ID: 28654796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.